Testing effectiveness (Phase 2)Ended earlyNCT02892734
What this trial is testing
Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer
Who this might be right for
HER2/Neu NegativeRecurrent Inflammatory Breast CarcinomaStage IV Breast Cancer+1 more
Northwestern University 3